Track topics on Twitter Track topics that are important to you
ANN ARBOR, Mich., March 03, 2017 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (“Company”), the leading developer of spider silk based fibers, today announced it has completed the planting of the first 2,000 mulberry trees at its Texas location. This facility and these trees will be used to supply the Company’s US recombinant spider silk operations with fresh mulberry leaves. The Company expects to begin harvesting these leaves in the 3rd or 4th quarter of this year.
“We’ve invested a tremendous amount of effort over the last thirty days preparing the new Texas facility and planting these first 2,000 trees,” said COO Jon Rice. “Those long days and a handful of fire ant bites have rewarded us, with what we expect will be, the capacity to support all of our US silk production without the need of expensive artificial diet. We’re looking forward to our first harvest this fall.”
The Company is now in the process of assessing its needs for additional mulberry trees and will make a decision regarding additional plantings later this year.
To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.kraiglabs.com/newsletter.
For more information about Spider Silk, check it out at www.kraiglabs.com/spider-silk.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Ben Hansel, Hansel Capital, LLC (720) 288-8495 ir@KraigLabs.comNEXT ARTICLE
Recombinant DNA is the formation of a novel DNA sequence by the formation of two DNA strands. These are taken from two different organisms. These recombinant DNA molecules can be made with recombinant DNA technology. The procedure is to cut the DNA of ...
Bioscience - any of the sciences that deal with living organisms. The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...